Use of a Phosphodiesterase Type 5 Inhibitor to Improve Anabolic Resistance in Older Adults
NCT05458232 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2024-11-04
Summary
This study will be the first demonstration of the utility and feasibility of Phosphodiesterase Type 5 inhibitor as an effective pharmacological therapy for improving anabolic resistant states.
Conditions
Interventions
- DRUG
-
Tadalafil 5mg
Subjects will ingest one 5mg tablet of tadalafil each evening for 14 days.
Sponsors & Collaborators
-
University of Arkansas
lead OTHER
Eligibility
- Min Age
- 60 Years
- Max Age
- 75 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-20
- Primary Completion
- 2023-01-20
- Completion
- 2023-01-20
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers
NCT00848081 ·Status: COMPLETED ·Phase: PHASE3
-
(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia
NCT05236634 ·Status: UNKNOWN ·Phase: NA
-
A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).
NCT02431754 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Tadalafil in Benign Prostatic Hyperplasia
NCT01183650 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects
NCT02839122 ·Status: COMPLETED ·Phase: PHASE1
-
Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and Tamsulosin
NCT01100021 ·Status: COMPLETED ·Phase: PHASE1
-
Administration of Tadalafil in Patients With Benign Prostatic Hyperplasia
NCT06466369 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients
NCT03246880 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Tadalafil After Radical Prostatectomy
NCT01026818 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Dr. Pyke's Supplement for Stream (S4S) in Men With Prostatism and ED
NCT03681392 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.
NCT01254071 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Tadalafil vs. Tadalafil With Sildosin in the Management of Moderately and Severely Symptomatic Patients of Prostatic Hyperplasia
NCT04577040 ·Status: UNKNOWN
-
Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
NCT04947631 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients with Prostate Volumes ≤ 40 Ml: a Prospective Comparative Study
NCT06809205 ·Status: COMPLETED ·Phase: PHASE4
-
Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia
NCT00077012 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease
NCT01685437 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker
NCT00680680 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
NCT05558007 ·Status: RECRUITING ·Phase: PHASE2
-
A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
NCT02326454 ·Status: COMPLETED ·Phase: PHASE2
-
Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
NCT03297398 ·Status: TERMINATED ·Phase: PHASE2
-
The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy
NCT05537272 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Tadalafil (5mg) For Treatment of Early Storage Symptoms and Erectile Dysfunction After Endoscopic Enucleation of Prostate
NCT05955001 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)
NCT00274417 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial in Males With BPH (Enlarged Prostate)
NCT00029822 ·Status: COMPLETED ·Phase: PHASE3
-
RT-310 Dose Escalation BPH Study
NCT06136819 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1